期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Emerging Trends of Drug-Resistant HIV-1 among Drug-Treated Patients in Former Blood Donors in Hubei,China:a Three-Year Surveillance from 2004 to 2006
1
作者 Jian Gong Xiao-qiong Wang +2 位作者 Xiao Tong Xi-hui Shen Rong- ge Yang 《Virologica Sinica》 SCIE CAS CSCD 2011年第6期386-392,共7页
This study aimed to evaluate emerging trends of drug resistance to nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) among 290 former blood donor HIV-1 inf... This study aimed to evaluate emerging trends of drug resistance to nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) among 290 former blood donor HIV-1 infected patients in Hubei, China, from 2004 to 2006, all of whom had received anti-HIV-1 therapy. The presence of NRTI- and NNRTI-associated mutations were established by sequencing; genotypic and predicted phenotypic drug resistance were evaluated using HIVdb Program version 5.0.1 (http://hivdb.stanford.edu/ pages/algs/HIVdb.html). Genotypic drug resistance analysis showed significant increases in percentages of patients carrying HIV-1 strains with M41L, T215Y/F, D67N, K103N, G190A/S, Y181C/F or L210W mutations. Of the variants' predicted phenotypic drug resistance, highly significant increases were detected in percentages of patients carrying HIV-1 with high resistance to zidovudine (AZT) or stavudine (D4T) in NRTIs, and to delavirdine (DLV), efavirenz (EFV) or nevirapine (NVP) in NNRTIs; intermediate resistance to abacavir (ABC), AZT, D4T, didanosine (DDI) or tenofovir disoproxil fumarate (TDF) in NRTIs, and to etravirine (ETR) in NNRTIs; and low and potential low resistance to lamivudine (3TC), ABC, emtricitabine (FTC) or TDF in NRTIs, and to ETR in NNRTIs. 展开更多
关键词 HIV-1 Drug-Resistant mutation Former blood donors Drug-treated
在线阅读 下载PDF
Temporal Trends and Characteristics of Immunization Consultation Hotline Calls—Suzhou City,Jiangsu Province,China,2018-2024
2
作者 Yunyan Zhang Jinling Gao +4 位作者 Lin Luan Juan Xu Benfeng Zheng Wenyu Wang Na Liu 《China CDC weekly》 2026年第12期353-358,I0005,共7页
Introduction:Vaccination remains a topic of widespread public concern.To ensure that professionals could deliver accurate information to the public directly and efficiently,Suzhou established a dedicated immunization ... Introduction:Vaccination remains a topic of widespread public concern.To ensure that professionals could deliver accurate information to the public directly and efficiently,Suzhou established a dedicated immunization program consultation hotline in 2018.To date,comprehensive,long-term standardized statistical analyses of immunization consultation hotlines in China remain scarce.This study analyzes temporal trends,category characteristics,and shifts in core public concerns regarding immunization consultations in Suzhou from 2018 to 2024,offering evidence to support the optimization of local public health service allocation.Methods:Dedicated professionals answered all calls in real time within a designated room(operating hours:9:00-17:00),and the full content of each call was recorded.Natural language processing(NLP)was applied for text preprocessing,categorical feature definition,frequency counting,and systematic analysis using Microsoft Excel.Descriptive statistics were performed and figures were generated using Python 3.12.1.Results:A total of 76,154 valid records were collected.Annual call volume peaked at 15,365 in 2021 before declining by 80%to 3,025 in 2024.Monthly call volumes were highest between May and September and lowest in January and February.The most common consultation category was assessment form-related inquiries(24,911;32.71%),followed by vaccination services(15,387;20.21%)and vaccination policies(15,026;19.73%).The most frequently consulted vaccines were the human papillomavirus vaccine(HPV)and the rabies vaccine(RV).Conclusions:The hotline served as a direct communication channel between the public and government,accurately reflecting dynamic shifts in public immunization demands while providing actionable support for immunization program.The evolving pattern of public vaccination concerns demonstrates measurable improvements in the quality and efficiency of immunization program in Suzhou. 展开更多
关键词 rabies vaccine consultation hotline temporal trends human papillomavirus vaccine public health service allocation vaccination services immunization vaccines
原文传递
Physical and toxicological profiles of human IAPP amyloids and plaques
3
作者 Aleksandr Kakinen Yunxiang Sun +9 位作者 Ibrahim Javed Ava Faridi Emily H.Pilkington Pouya Faridi Anthony W.Purcell Ruhong Zhou Feng Ding Sijie Lin Pu Chun Ke Thomas P.Davis 《Science Bulletin》 SCIE EI CAS CSCD 2019年第1期26-35,共10页
Although much has been learned about the fibrillization kinetics, structure and toxicity of amyloid proteins, the properties of amyloid fibrils beyond the saturation phase are often perceived as chemically and biologi... Although much has been learned about the fibrillization kinetics, structure and toxicity of amyloid proteins, the properties of amyloid fibrils beyond the saturation phase are often perceived as chemically and biologically inert, despite evidence suggesting otherwise. To fill this knowledge gap, we examined the physical and biological characteristics of human islet amyloid polypeptide(IAPP) fibrils that were aged up to two months. Not only did aging decrease the toxicity of IAPP fibrils, but the fibrils also sequestered fresh IAPP and suppressed their toxicity in an embryonic zebrafish model. The mechanical properties of IAPP fibrils in different aging stages were probed by atomic force microscopy and sonication, which displayed comparable stiffness but age-dependent fragmentation, followed by self-assembly of such fragments into the largest lamellar amyloid structures reported to date. The dynamic structural and toxicity profiles of amyloid fibrils and plaques suggest that they play active, long-term roles in cell degeneration and may be a therapeutic target for amyloid diseases. 展开更多
关键词 IAPP AMYLOID PLAQUE Self assembly Toxicity
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部